NYSEARCA:SCID Global X Scientific Beta Europe ETF (SCID) Price, Holdings, & News → The World's First '$20 Trillion Drug?' (From Behind the Markets) (Ad) Free SCID Stock Alerts $24.62 0.00 (0.00%) (As of 08/21/2020) Add Compare Share Share Today's Range$24.57▼$24.6250-Day Range$24.62▼$24.6252-Week Range$16.29▼$26.43Volume4,800 shsAverage Volume1,307 shsMarket Capitalization$3.69 millionAssets Under Management$3.70 millionDividend Yield1.83%Net Expense Ratio0.38% Stock AnalysisStock Analysis Get Global X Scientific Beta Europe ETF alerts: Email Address About Global X Scientific Beta Europe ETFRead More SCID Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart SCID ETF News HeadlinesNo headlines for this company have been tracked by MarketBeat.com Receive SCID Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Global X Scientific Beta Europe ETF and its competitors with MarketBeat's FREE daily newsletter. Email Address Fund Details IssuerGlobal X Fund NameGlobal X Scientific Beta Europe ETF Tax ClassificationRegulated Investment Company Stock ExchangeNYSEARCACurrent SymbolNYSEARCA:SCID Inception Date5/12/2015 Fund ManagerChang Kim, James Ong, Nam To WebN/A PhoneN/AFund Focus Asset ClassEquity BenchmarkScientific Beta Extended Europe Multi-Beta Multi-Strategy Equal Risk Contribution Index CategoryBroad Equity FocusBroad Equity Development LevelDeveloped Markets RegionEurope Number of Holdings0 Fund Statistics Assets Under Management$3.70 million Average Daily Volume$976.40 Discount/Premium-0.05% Administrator, Advisor and Custodian AdministratorGlobal X Management Company LLC AdvisorGlobal X Management Company LLC CustodianBrown Brothers Harriman & Co. DistributorSEI Investments Distribution Co. Transfer AgentBrown Brothers Harriman & Co. TrusteeN/A Lead Market MakerSusquehanna Miscellaneous Outstanding Shares150,000BetaN/A The 10 Best AI Stocks to Own in 2024Wondering where to start (or end) with AI stocks? These 10 simple stocks can help investors build long-term wealth as artificial intelligence continues to grow into the future.Get This Free Report Ad DTIHow a $0.25 cent option contract makes my top traders feelIf you don’t know me, I’ve been in the markets for over 40 years… but recently, I’ve discovered a breakthrough that might be my favorite strategy of ALL time! While I kept the finer details of these $0.25 Cent Trades under wraps until recently…Click now to see for yourself what $0.25 Cent Trades is all about Global X Scientific Beta Europe ETF ExpensesTypeSCIDBroad Equity ETFsEquity ETFsNYSEARCA ETFsAll ETFsManagement Fee0.38%0.52%0.54%0.50%0.51%Other Expenses0.00%0.53%0.54%0.64%0.58%Total Expense0.38%0.77%0.70%0.74%0.70%Fee Waiver0.00%-0.41%-0.55%-0.68%-0.57%Net Expense0.38%0.62%0.60%0.58%0.58% Global X Scientific Beta Europe ETF (SCID)Full Holdings Details Similar ETFsXtrackers FTSE Emerging Comprehensive Factor ETFNYSEARCA:DEMGStrategy Shares US Market Rotation Strategy ETFNYSEARCA:HUSEFlexShares Currency Hedged Morningstar EM Factor Tilt Index FundNYSEARCA:TLEHDirexion Daily S&P Expanded Tech Software Sector Bull 2X SharesNYSEARCA:SWARETRACS Monthly Pay 2xLeveraged Wells Fargo MLP Ex-Energy ETN Series BNYSEARCA:LMLB SCID ETF - Frequently Asked Questions How have SCID shares performed in 2024? Global X Scientific Beta Europe ETF's stock was trading at $24.62 on January 1st, 2024. Since then, SCID shares have increased by 0.0% and is now trading at $24.62. View the best growth stocks for 2024 here. What does SCID invest in? Global X Scientific Beta Europe ETF is a equity fund issued by Global X. SCID focuses on broad equity investments and follows the Scientific Beta Extended Europe Multi-Beta Multi-Strategy Equal Risk Contribution Index. The fund's investments total to approximately $3.70 million assets under management. What is the management fee for Global X Scientific Beta Europe ETF? Global X Scientific Beta Europe ETF's management fee is 0.38% and has no other recorded expenses or fee waivers. The net expense ratio for SCID is 0.38%. How do I buy shares of Global X Scientific Beta Europe ETF? Shares of SCID stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. This page (NYSEARCA:SCID) was last updated on 4/25/2024 by MarketBeat.com Staff From Our PartnersThese AI trades triggered this morning (545% return)Prosper Trading AcademyConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsThe A.I. story nobody is telling you (Read ASAP)TradeSmithHe Is Giving Away BitcoinCrypto Swap ProfitsJim Cramer’s “The Biggest Drug Ever”Behind the MarketsYour Money is Not SafeAmerican AlternativeThe AI stock to buy right nowStockEarningsThe only accurate crypto trading system I know …Weiss Ratings Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Global X Scientific Beta Europe ETF Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
